Latest Breaking News On - Adiso therapeutics inc - Page 1 : comparemela.com

Geneoscopy and Adiso Therapeutics Announce Strategic Collaboration to Investigate New Therapeutic Options for Patients with Inflammatory Bowel Disease

ST. LOUIS, Mo. & CONCORD, Mass. (BUSINESS WIRE) Dec 5, 2023

United statesUniversity of massachusettsAndrea sampsonCarrie mendivil jiScott megaffinCollin beloinSarah sutton liza sullivanAndrew barnellSampson public relations groupUniversity of edinburgh centre for inflammation researchMicrobiome instituteGeneoscopy incUniversity college corkGilmartin groupAdiso therapeutics incUniversity of massachusetts chan medical school

Geneoscopy and Adiso Therapeutics Announce Strategic Collaboration to Investigate New Therapeutic Op

Adiso to Utilize Noninvasive RNA Technology Developed by Geneoscopy as a Precision Immunology Measure in ADS051 Phase 2 IBD TrialST. LOUIS, Mo. & CONCORD, Mass. (BUSINESS WIRE) Geneoscopy, Inc., a life sciences company focused on developing noninvasive diagnostic and precision medicine tools for gastrointestinal h.

United statesAndrea sampsonSarah sutton liza sullivanScott megaffinCarrie mendivil jiCollin beloinAndrew barnellMicrobiome instituteUniversity college corkSampson public relations groupGilmartin groupUniversity of edinburgh centre for inflammation researchUniversity of massachusetts chan medical schoolGeneoscopy incAdiso therapeutics incUtilize noninvasive

Adiso Therapeutics to Participate in Upcoming September Investor Conferences

Adiso Therapeutics to Participate in Upcoming September Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

University collegeNew south walesNew yorkUnited statesJennifer lockeJason finkelsteinSarah sutton liza sullivanScott megaffinAdiso therapeutics incMicrobiome instituteLotte new york palace hotelPrnewswire adiso therapeutics incUniversity of edinburgh centre for inflammation researchIntercontinental barclay hotelUniversity of massachusetts chan medical schoolChief executive officer

Adiso Therapeutics Announces Publication of Compelling Preclinical Research on ADS051, a First-in-Class Oral, Gut-restricted, Small Molecule Modulator of Neutrophil Trafficking and Activation

Adiso Therapeutics Announces Publication of Compelling Preclinical Research on ADS051, a First-in-Class Oral, Gut-restricted, Small Molecule Modulator of Neutrophil Trafficking and Activation
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sarah suttonChris murphyEliza sullivanJennifer lockeJason finkelsteinAdiso therapeutics incDrug administrationPrnewswire adiso therapeutics incWiley online libraryVice presidentChief operatingBusiness officer

Adiso Therapeutics Announces Publication in Journal of Clinical & Translational Immunology Highlighting the ADS032 Mechanism of Action

/PRNewswire/ Adiso Therapeutics, Inc., a clinical-stage biotechnology company developing novel medicines targeting chronic inflammatory diseases, today.

United kingdomEdinburgh bioquarterJason finkelsteinScott megaffinSarah sutton liza sullivanJennifer lockeAdrianog rossiUniversity of massachusetts chan medical schoolAdiso therapeutics incWiley online libraryInstitute for regenerationUniversity of edinburgh centre for inflammation researchPrnewswire adiso therapeutics incTranslational immunologyEdinburgh centreInflammation research